A retrospective study of premorbid ability and aging differences in cognitive clusters of schizophrenia

Psychiatry Research

Volumn 118, Issue 3, 2003, Pages 209-221

  Horan, William P ^a   Goldstein, Gerald ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Cognitive functioning; Schizophrenia; Wisconsin Card Sorting Test

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CLUSTER ANALYSIS; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; INTELLIGENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEUROPSYCHOLOGICAL TEST; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROBLEM SOLVING; PSYCHOMETRY; RETROSPECTIVE STUDY; SCHIZOPHRENIA; TIME; VALIDATION PROCESS; WISCONSIN CARD SORTING TEST;

EID: 0038771181     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(03)00078-7     Document Type: Article

References (47)

1. Aldenderfer M.S., Blashfield R.K. Cluster Analysis. 1984;Sage Publications, Beverly Hills, CA.
2. Allen D.N., Goldstein G., Warnock E. A consideration of neuropsychologically normal schizophrenia. Journal of the International Neuropsychological Society. 9:2003;56-63.
3. Diagnostic and Statistical Manual of Mental Disorders. third ed: 1987;American Psychiatric Press, Washington, DC.
4. Cuesta M.J., Peralta V., Zarzuela A. Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study. Schizophrenia Research. 48:2001;17-28.
5. Dalby J.T., Williams R. Preserved reading and spelling ability in psychotic disorders. Psychological Medicine. 16:1986;171-175.
6. Franzen M.D., Burgess E.J., Smith-Seemiller L. Methods of estimating premorbid intellectual function. Archives of Clinical Neuropsychology. 12:1997;711-738.
7. Friedman J.I., Harvey P.D., Coleman T., Moriarty P.J., Bowie C., Parrella M., White L., Adler D., Davis K.L. Six-year follow-up of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. American Journal of Psychiatry. 158:2001;1441-1448.
8. Fucetola R., Seidman L.J., Kremen W.S., Faraone S.V., Goldstein J.M., Tsuang M.T. Age and neuropsychologic function in schizophrenia: a decline in executive abilities beyond that observed in healthy volunteers. Biological Psychiatry. 48:2000;137-146.
9. Gold S., Arndt S., Nopoulos P., O'Leary D.S., Andreasen N.C. Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. American Journal of Psychiatry. 156:1999;1342-1348.
10. Goldberg T.E., Torrey E.F., Gold J.M., Bigelow L.B., Ragland R.D., Taylor E., Weinberger D.R. Genetic risk for neuropsychological impairment in schizophrenia: a study of monozygotic twins discordant and concordant for the disorder. Schizophrenia Research. 17:1995;77-84.
11. Goldstein G. Neuropsychological heterogeneity in schizophrenia: a consideration of abstraction and problem-solving abilities. Archives of Clinical Neuropsychology. 5:1990;251-264.
12. Goldstein G., Allen D.N., van Kammen D.P. Individual differences in cognitive decline in schizophrenia. American Journal of Psychiatry. 155:1998;1117-1118.
13. Goldstein G., Shemansky W.J. Influences on cognitive heterogeneity in schizophrenia. Schizophrenia Research. 18:1995;59-69.
14. Goldstein G., Zubin J. Neuropsychological differences between young and old schizophrenics with and without associated neurological dysfunction. Schizophrenia Research. 3:1990;117-126.
15. Green M.F. Schizophrenia from a Neurocognitive Perspective: Probing the Impenetrable Darkness. 1998;Allyn and Bacon, Inc, Needham Heights, MA.
16. Harvey P.D., Silverman J.M., Mohs R.C., Parrella M., White L., Powchik P., Davidson M., Davis K.L. Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients. Biological Psychiatry. 45:1999;32-40.
17. Harvey P.D., Moriarty P.J., Friedman J.L., White L., Parrella M., Mohs R.C., Davis K.L. Differential preservation of cognitive functions in geriatric patients with lifelong chronic schizophrenia: less impairment in reading compared with other skill areas. Biological Psychiatry. 47:2000;962-968.
18. Heaton R.K., Drexler M. Clinical neuropsychological findings in schizophrenia and aging. Miller N.E., Cohen G.D. Schizophrenia and Aging: Schizophrenia, Paranoia, and Schizophreniform Disorders in Later Life. 1987;145-161 The Guilford Press, New York.
19. Heaton R.K., Chelune G.J., Talley J.L., Kay G.G., Curtiss G. Wisconsin Card Sorting Test Manual. 1993;Psychological Assessment Resources, Odessa, FL.
20. Heaton R.K., Grant I., Matthews C.G. Differences in neuropsychological test performance associated with age, education, and sex. Grant I., Adams K.M. Neuropsychological Assessment of Neuropsychiatric Disorders. 1986;100-120 Oxford University Press, New York.
21. Heaton R.K., Grant I., Matthews C.G. Comprehensive Norms for an Expanded Halstead-Reitan Battery. 1991;Psychological Assessment Resources, Odessa, FL.
22. Heinrichs R.W., Ruttan L., Zakzanis K.K., Case D. Parsing schizophrenia with neurocognitive tests: evidence of stability and validity. Brain and Cognition. 35:1997;207-224.
23. Horan W.P., Goldstein G. Correlations between age and higher cognitive function in schizophrenia subgroups. Schizophrenia Research. 61:2003;325-326.
24. Jastak J.F., Jastak S.R. The Wide Range Achievement Test Manual. 1965;Guidance Associates, Wilmington, DE.
25. Jastak S., Wilkinson G.S. Wide Range Achievement Test-Revised: Administration Manual. 1984;Jastak Associates, Wilmington, DE.
26. Keefe R.S.E., Mohs R.C., Losonczy M.F., Davidson M., Silverman J.M., Kendler K.S., Horvath T.B., Nora R., Davis K.L. Characteristics of very poor outcome schizophrenia. American Journal of Psychiatry. 144:1987;889-895.
27. Kremen W.S., Seidman L.J., Faraone S.V., Pepple J.R., Lyons M.J., Tsuang M.T. The '3 Rs' and neuropsychological function in schizophrenia: an empirical test of the matching fallacy. Neuropsychology. 1:1996;22-31.
28. Kremen W.S., Seidman L.J., Faraone S.V., Toomey R., Tsuang M.T. The paradox of normal neuropsychological function in schizophrenia. Journal of Abnormal Psychology. 109:2000;743-752.
29. Nelson H.E. National Adult Reading Test (NART) Manual. 1982;NFER-Nelson Publishing Co, Windsor, UK.
30. Palmer B.W., Heaton R.K., Paulsen J.S., Kuck J., Braff D., Harris M.J., Zisook S., Jeste D.V. Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology. 11:1997;437-446.
31. Paulsen J.S., Heaton R.K., Sadek J.R., Perry W., Delis D.C., Braff D., Kuck J., Zisook S., Jeste D.V. The nature of learning and memory impairment in schizophrenia. Journal of the International Neuropsychological Society. 1:1995;88-99.
32. Purdon S.F., Malla A., Labelle A., Lit W. Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol. Journal of Psychiatry and Neuroscience. 26:2001;137-149.
33. Reitan R.M., Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. second ed: 1993;Neuropsychology Press, Tucson, AZ.
34. Reitan R.M., Wolfson D. Influence of age and education on neuropsychological test results. The Clinical Neuropsychologist. 9:1995;151-158.
35. Ryan C., Butters N. Learning and memory impairments in young and old alcoholics: evidence for the premature-aging hypothesis. Alcoholism: Clinical and Experimental Research. 4:1980;288-293.
36. Russell A.J., Munro J.C., Jones P.B., Hemsley D.R., Murray R.M. Schizophrenia and the myth of intellectual decline. American Journal of Psychiatry. 154:1997;635-639.
37. Russell E.W., Neuringer C., Goldstein G. Assessment of Brain Damage: A Neuropsychological Key Approach. 1970;Wiley-Interscience, New York.
38. Satz P. Brain reserve capacity on symptom onset after brain injury: a formulation and review of evidence for threshold theory. Neuropsychology. 7:1993;273-295.
39. Sautter F.J., McDermott B.E., Cornwell J., Johnson J., Borges A., Wilson A.F., Vasterling J.J., Foundas A.L. A preliminary study of the neuropsychological heterogeneity of familial schizophrenia. Schizophrenia Research. 18:1995;1-7.
40. Seaton B.E., Allen D.N., Goldstein G., Kelley M.E., van Kammen D.P. Relations between cognitive and symptom profile heterogeneity in schizophrenia. Journal of Nervous and Mental Disease. 187:1999;414-419.
41. Seaton B.E., Goldstein G., Allen D.N. Sources of heterogeneity in schizophrenia: the role of neuropsychological functioning. Neuropsychology Review. 11:2001;45-67.
42. Spitzer R.L., Williams J.B.W., Gibbon M., First M.B. Structured Clinical Interview for DSM-III-R (SCID-P). 1989;New York State Psychiatric Institute, New York.
43. Velligan D.I., Newcomer J., Pultz J., Csernansky J., Hoff A.L., Mahurin R., Miller A.L. Does cognitive function improve with quetiapine in comparison to haloperidol? Schizophrenia Research. 53:2002;239-248.
44. Warnock E.L., Allen D.N., Goldstein G. Neuropsychologically normal schizophrenia? (Abstract). Archives of Clinical Neuropsychology. 15:2000;758.
45. Wechsler D. Manual for the Wechsler Adult Intelligence Scale. 1955;Psychological Corporation, New York.
46. Wechsler D. Wechsler Adult Intelligence Scale-Revised. 1981;The Psychological Corporation, San Antonio, TX.
47. Weichert T.W., Goldberg T.E., Gold J.M., Bigelow L.G., Egan M.F., Weinberger D.R. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Archives of General Psychiatry. 57:2000;907-913.